FPIN's clinical inquiries. Combination therapy for postmenopausal osteoporosis.
Howard
Ellen
E
University of Washington Health Science Libraries, Seattle, WA, USA.
Tagliarino-Jones
Heather
H
D019386:Alendronate / Q000008:administration & dosage; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D004164:Diphosphonates / Q000008:administration & dosage; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000008:administration & dosage; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D010281:Parathyroid Hormone; D020849:Raloxifene Hydrochloride; D019386:Alendronate